Lidocain Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, stabilizing them in an inactive state. This prevents the rapid influx of sodium ions needed for action potential generation, thereby halting the transmission of pain signals and producing a localized loss of sensation.

The specific dose of Lidocain Noridem is determined by the prescribing clinician based on the procedure, patient weight, age, and clinical condition. Dosage is individualized, and the prescriber will calculate the appropriate amount and concentration for each administration.

Safety data for lidocaine in pregnancy and lactation are limited. It is generally used only when the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate each case carefully and consider alternative options when appropriate.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with longer‑acting agents such as bupivacaine, lidocaine has a faster onset and a shorter duration of action, making it suitable for procedures requiring rapid, temporary anesthesia. Its safety profile is well‑established, though systemic toxicity can occur at high doses, similar to other amide‑type anesthetics.

Store the product at room temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperatures. Ensure the container is tightly sealed to maintain sterility until use.

Lidocain Noridem is supplied as a sterile solution and can be administered via epidural, intradermal or intramuscular injection. The route and technique are chosen by the clinician based on the intended indication and patient factors.

Serious risks include systemic toxicity leading to central nervous system seizures, cardiovascular arrhythmias, severe hypotension, allergic reactions such as anaphylaxis, and rare cases of methemoglobinemia. Prompt recognition and management of these events are essential.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid its use. It is also contraindicated in individuals with certain cardiac conduction disorders, severe hepatic impairment, or those taking medications that markedly increase lidocaine plasma levels without appropriate monitoring.